Trials / Conditions / Chlamydia Trachomatis

Chlamydia Trachomatis

25 registered clinical trials studyying Chlamydia Trachomatis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Healthy Expectancy Through Routine Antenatal STI Screening NCT07458802	Adriane Wynn	N/A
Active Not Recruiting	Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in Germany NCT07002047	Sanofi	—
Recruiting	Time to Clearance of Chlamydia Trachomatis and Neisseria Gonorrhoeae RNA After Treatment: a Prospective Cohort NCT06216964	University Hospital, Strasbourg, France	N/A
Completed	Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile) NCT04446611	Foundation for Professional Development (Pty) Ltd	N/A
Completed	Self Sampling for Rapid Turnaround Testing in the Emergency Department NCT03676816	University of California, San Francisco	N/A
Completed	Evaluation of the Atlas Genetics io® CTNG System NCT03071510	Binx Health Limited	—
Completed	Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years NCT02787109	Statens Serum Institut	Phase 1
Terminated	Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples NCT02795975	Hologic, Inc.	—
Completed	Multimedia WORTH With Black Drug-Involved Women on Probation NCT02391233	Columbia University	N/A
Completed	A Randomized Online Health Experiment for a Safer Youth Sexual Behaviour NCT02128620	University Hospital of North Norway	N/A
Completed	Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System NCT01733069	Gen-Probe, Incorporated	—
Withdrawn	Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System NCT01358799	Gen-Probe, Incorporated	—
Unknown	Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced NCT01661985	Ostergotland County Council, Sweden	Phase 4
Completed	Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy NCT00978848	University of Pittsburgh	—
Completed	Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients NCT00973466	Insel Gruppe AG, University Hospital Bern	—
Completed	Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger NCT00618449	University of California, San Francisco	Phase 4
Completed	Washington State Community Expedited Partner Treatment (EPT) Trial NCT01665690	University of Washington	Phase 4
Completed	Home Sampling Versus Conventional Sampling for Screening of Urogenital Chlamydia Trachomatis in Young Men and NCT00283127	Norwegian Institute of Public Health	N/A
Completed	Optimizing Strategies to Improve STD Partner Services NCT00207454	Centers for Disease Control and Prevention	Phase 1
Completed	Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand NCT00213057	Population Council	Phase 1
Completed	Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers NCT01329588	CHU de Quebec-Universite Laval	Phase 4
Completed	Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide NCT00213031	Population Council	Phase 2
Completed	Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission NCT00213018	Population Council	Phase 2
Completed	Home Screening for Chlamydia Surveillance NCT00177437	University of Pittsburgh	Phase 3
Completed	Randomized Population-Based Study on Chlamydia Trachomatis Screening NCT00827970	University of Aarhus	N/A